Article
Adequate Underrepresented Minority Representation in Cancer Trials: Evidence from an NCI-Designated Center in a Minority County
2025-04-21
Abstract excerpt
<h4>Background: </h4> Significant racial and ethnic disparities continue to persist in clinical trial enrollment. This limits the generalizability of clinical trial data and consequently the application of novel therapeutics for diverse populations. We hypothesized that enrollment of underrepresented minorities (URM) is feasible, with improved access to clinical care and a tailored clinical trial portfolio address...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 840bf470-ae76-5927-b2cd-4648bff22e6c
- DOI
- 10.22541/au.174524077.78834283/v1
